Financhill
Back

GSK PLC Quote, Financials, Valuation and Earnings

GSK PLC Price Quote

$36.72
-0.29 (-0.78%)
(Updated: October 31, 2024 at 6:55 PM ET)

GSK PLC Key Stats

Sell
22
GSK PLC (GSK) is a Sell

Day range:
$36.28 - $37.23
52-week range:
$33.68 - $45.93
Dividend yield:
4.01%
P/E ratio:
12.79
P/S ratio:
1.98
P/B ratio:
4.28%

Volume:
13.2M
Avg. volume:
5.3M
1-year change:
4.93%
Market cap:
$77.8B
Revenue:
$37.7B
EPS:
$2.48

How Much Does GSK PLC Make?

  • How Much Are GSK PLC's Sales Annually?
    GSK Revenues are $37.7B
  • How Much Profit Does GSK PLC's Make A Year?
    GSK net income is $6.1B

Is GSK PLC Growing As A Company?

  • What Is GSK PLC's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.11%
  • What Is GSK PLC's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.1%

GSK PLC Stock Price Performance

  • Did GSK PLC Stock Go Up Last Month?
    GSK PLC share price went down by -9.47% last month
  • Did GSK's Share Price Rise Over The Last Year?
    GSK share price rose by 4.93% over the past 1 year

What Is GSK PLC 52-Week High & Low?

  • What Is GSK PLC’s 52-Week High Share Price?
    GSK PLC has traded as high as $45.93 over the past 52 weeks
  • What Is GSK PLC’s 52-Week Low Share Price?
    GSK PLC has traded as low as $33.68 over the past 52 weeks

GSK PLC Price To Free Cash Flow

  • Is GSK PLC Stock Overvalued?
    GSK PLC is trading at a price to free cash flow ratio of 12.13
  • Is GSK PLC Stock Undervalued?
    GSK PLC EV to Free Cash Flow ratio is 14.62
  • What Is GSK PLC’s Price Earnings Growth Ratio?
    GSK PEG ratio is 0.00
  • Is GSK PLC Trading At A Premium To Earnings?
    GSK PLC EV to EBIT ratio is 13.16

Is It Risky To Buy GSK PLC?

  • How Much Debt Does GSK PLC Have?
    Total long term debt quarterly is $21.4B
  • How Much Cash Does GSK PLC Have?
    Cash and short term investments quarterly total is $3.8B
  • What Is GSK PLC’s Book Value Per Share?
    Book value per share is 8.91

Is GSK PLC Cash Flow Positive?

  • What Is GSK Cash Flow From Operations?
    Cash flow from operations (TTM) is $9.3B
  • What Is GSK PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$10B
  • What Is GSK PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $516.1M

GSK PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    GSK return on invested capital is 12.81%
  • What Is GSK PLC Return On Assets?
    ROA measures how assets are converting to revenues and is 6.85%
  • What Is GSK Return On Equity?
    ROE is a measure of profitability and is 31.39%

GSK PLC Earnings Date & Stock Price

  • What Is GSK PLC's Stock Price Today?
    A single share of GSK can be purchased today for 37.01
  • What Is GSK PLC’s Stock Symbol?
    GSK PLC trades on the nyse under the ticker symbol: GSK
  • When Is GSK PLC’s Next Earnings Date?
    The next quarterly earnings date for GSK PLC is scheduled on February 5, 2025
  • When Is GSK's next ex-dividend date?
    GSK PLC's next ex-dividend date is November 15, 2024
  • How To Buy GSK PLC Stock?
    You can buy GSK PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

GSK PLC Competitors

  • Who Are GSK PLC's Competitors?
    Below is a list of companies who compete with GSK PLC or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • AstraZeneca PLC (AZN)
    • Moderna Inc (MRNA)
    • Pfizer Inc (PFE)
    • TC BioPharm (Holdings) PLC (TCBP)

GSK PLC Dividend Yield

  • What Is GSK Dividend Yield?
    GSK PLC’s dividend yield currently is 4.01%
  • What Is GSK PLC’s Payout Ratio?
    GSK PLC’s payout ratio is 57.77%
  • When Did GSK PLC Last Pay A Dividend?
    The latest dividend pay date is November 1, 2024
  • What Is GSK PLC’s Dividend Per Share?
    GSK PLC pays a dividend of $0.38 per share

GSK PLC Analyst Estimates

YoY Growth Past Surprise
EPS: -9.55% 13.17%
Revenue: 10.72% 5.21%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 48.20
Upside from Last Price: 30.24%

Major Shareholders

  • How many GSK shares are owned by institutional investors?
    359.6M GSK shares are owned by institutional investors
  • How many GSK shares are owned by insiders?
    8M GSK shares are owned by insiders